| Page | Contents |
|---|---|
| 10.01 | Haematological cancers • ALL• CLL • Hairy cell leukaemia • AML• CML• Myelofibrosis • Myelodysplastic syndrome • Polycythaemia vera |
| 10.02 | Haematological cancers • Non-Hodgkin's lymphoma • Hodgkin's lymphoma • Multiple myeloma |
| 10.03 | Primary immunodeficiencies • Neutrophilia / phagocytes • T-cell disorders, incl DiGeorge's • B & T-cell disorders, incl SCID • Acute intermittent porphyria |
| 10.04 | Anaemia • DDx chart + iron studies interpretation • Microcytic anaemia |
| 10.05 | Anaemia • Normocytic anaemia ÷ non-haemolytic and haemolytic |
| 10.06 | • Microcytic anaemia • Methaemoglobinaemia • Thrombophilia • Antiphospholipid syndrome • Thrombocytosis |
| 10.07 | Platelet disorders • Immune thrombocytopaenia • Thrombocytopaenia • Haemophilia • von Willebrand disease • Neutropaenia |
| 10.08 | Blood products • Packed red cells • Platelets • CMV-ve and irradiated blood • FFP & cryoprecipitate • Prothrombin complex • Cell saver devices • Warfarin – Mx of high INR • Blood product transfusion complications, incl TACO, TRALI |
| 10.09 | Miscellaneous • Hereditary angioedema • Hyposplenism• Splenomegaly • Thymoma• Lymphadenopathy • Drugs – anticoagulants, antiplatelets, tranexamic acid |
| 10.10 | Emergencies, organ transplants • Neutropenic sepsis • Tumour lysis syndrome • Graft versus host disease (GVHD) • Superior vena cava syndrome • Organ transplant & rejection |
| 10.11 | • Common cancers• Tumour markers • Genetic conditions predisposing to cancer • Prescribing for palliative / end of life care |
| 10.12 | Breast • Breast Ca• Fibroadenoma • Fibrocystic breast changes • Fat necrosis• Lipoma • Phyllodes tumour• Galactocele • Mammary duct ectasia • Duct papilloma• Lump description |
